[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Schraa et al., 2022 - Google Patents

Cell-free circulating (tumor) DNA before surgery as a prognostic factor in non-metastatic colorectal cancer: a systematic review

Schraa et al., 2022

View HTML
Document ID
17258229007781022264
Author
Schraa S
van Rooijen K
Koopman M
Vink G
Fijneman R
Publication year
Publication venue
Cancers

External Links

Snippet

Simple Summary Patients with colorectal cancer without distant metastases are often cured by surgical tumor resection. Follow-up is needed because of the risk of disease recurrence. Patients at risk of disease recurrence may benefit from additional chemotherapy. Detection …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/01Social networking
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology

Similar Documents

Publication Publication Date Title
Moody et al. The efficacy of miR-20a as a diagnostic and prognostic biomarker for colorectal cancer: a systematic review and meta-analysis
Schraa et al. Cell-free circulating (tumor) DNA before surgery as a prognostic factor in non-metastatic colorectal cancer: a systematic review
Shi et al. Frequent gene amplification predicts poor prognosis in gastric cancer
Nakamura et al. Circulating microRNA panel as a potential novel biomarker for oral squamous cell carcinoma diagnosis
Swets et al. Tumor LINE-1 methylation level in association with survival of patients with stage II colon cancer
Tonella et al. Prognostic and predictive biomarkers in stage III melanoma: Current insights and clinical implications
Abudukadeer et al. Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients
Thiele et al. lncRNAs in non-malignant tissue have prognostic value in colorectal cancer
Batista et al. TERT promoter mutation as a potential predictive biomarker in BCG-treated bladder cancer patients
Carrasco et al. Cell-free DNA as a prognostic biomarker for monitoring muscle-invasive bladder cancer
Adam-Artigues et al. Identification of a two-microRNA signature in plasma as a novel biomarker for very early diagnosis of breast cancer
Park et al. MicroRNA profile for diagnostic and prognostic biomarkers in thyroid cancer
Harsanyi et al. Biomarkers of bladder cancer: cell-free DNA, epigenetic modifications and non-coding RNAs
Sequeira et al. LiKidMiRs: A ddPCR-based panel of 4 circulating miRNAs for detection of renal cell carcinoma
Tsiakanikas et al. High expression of a tRNAPro derivative associates with poor survival and independently predicts colorectal cancer recurrence
Souza et al. Liquid biopsy in lung cancer: biomarkers for the management of recurrence and metastasis
Nørgaard et al. Comprehensive evaluation of TFF3 promoter hypomethylation and molecular biomarker potential for prostate cancer diagnosis and prognosis
Wang et al. Automatic detection of the circulating cell-free methylated DNA pattern of GCM2, ITPRIPL1 and CCDC181 for detection of early breast cancer and surgical treatment response
Ntzifa et al. DNA methylation analysis in plasma cell-free DNA and paired CTCs of NSCLC patients before and after osimertinib treatment
Chang et al. Associations of timp-3 genetic polymorphisms with egfr statuses and cancer clinicopathologic development in lung adenocarcinoma patients
Hsieh et al. Impact of matrix metalloproteinase-11 gene polymorphisms on biochemical recurrence and clinicopathological characteristics of prostate cancer
Kunac et al. Activation of cGAS-STING Pathway Is associated with MSI-H Stage IV colorectal cancer
Dudea-Simon et al. Alteration of gene and miRNA expression in cervical intraepithelial neoplasia and cervical cancer
Lee et al. Predictive value of circulating miRNAs in lymph node metastasis for colon cancer
Kottorou et al. Differentially methylated ultra-conserved regions Uc160 and Uc283 in adenomas and adenocarcinomas are associated with overall survival of colorectal cancer patients